As of 2025-05-20, the Relative Valuation of Vascular Biogenics Ltd (VBLT) is (3.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.16 USD, the upside of Vascular Biogenics Ltd based on Relative Valuation is -2576.5%.
The range of the Relative Valuation is (3.21) - (4.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 20.0x | 18.2x |
| Forward P/E multiples | 15.6x - 19.8x | 19.4x |
| Fair Price | (3.21) - (4.08) | (3.86) |
| Upside | -2160.3% - -2713.5% | -2576.5% |
| Date | P/E |